[在用卡博普拉丁和佩米特雷克塞德联合治疗布罗利祖马布后致死性肝炎]
Rasmus Strøm Risbjerg1, Niels Kristian Aagaard1, Lisbet Grønbæk2
1Lever-, Mave- og Tarmsygdomme, Aarhus Universitetshospital.
Ugeskrift for laeger
|January 3, 2025
概括
免疫检查点抑制剂可以导致免疫疗法诱导的肝炎. 在接受联合癌症治疗的患者中,尽管接受治疗,但发生了一种罕见的致命性肝衰竭病例.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 广泛用于癌症治疗.
- 免疫疗法诱导的肝炎是ICI的一种已知的副作用.
- 由ICI引起的肝毒性通常可以用皮质类固醇治疗.
更多相关视频
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
348
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.7K
相关概念视频
01:27Tumor Immunotherapy
394
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
394
02:50Combination Therapies and Personalized Medicine
4.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.7K